GSK PLC (LSE:GSK)
£ 13.97 0.16 (1.16%) Market Cap: 57.00 Bil Enterprise Value: 69.85 Bil PE Ratio: 22.90 PB Ratio: 4.07 GF Score: 69/100

GSK plc Getting ahead of HIV with ViiV Management Presentation Transcript

Sep 28, 2023 / 01:00PM GMT
Release Date Price: £14.94 (-1.62%)

Sep 28, 2023 / 01:00PM GMT
Presentation
Sep 28, 2023 / 01:00PM GMT

=====================
Corporate Participants
=====================
* David Simon Redfern
GSK plc - President of Corporate Development
* Deborah Jayne Waterhouse
GSK plc - CEO of ViiV Healthcare & President of Global Health
* Kimberly Smith
ViiV Healthcare Limited - Head of Global Research & Medical Strategy
* Nick Stone

=====================
Conference Call Participants
=====================
* Andrew Simon Baum
Citigroup Inc., Research Division - Global Head of Healthcare Research and MD
* Emmanuel Douglas Papadakis
Deutsche Bank AG, Research Division - Research Analyst
* Eric Le Berrigaud
Stifel, Nicolaus & Company, Incorporated, Research Division - Research Analyst
* Graham Glyn Charles Parry
BofA Securities, Research Division - MD and Head of Healthcare Equity Research
* James Daniel Gordon
JPMorgan Chase & Co, Research Division - Senior Analyst
* Kerry Ann Holford
Joh. Berenberg

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot